Departamento académico
(FM) Endocrinología y Nutrición
Publications (29) Publications auxquelles un chercheur a participé
2024
-
Cardiometabolic risk stratification using a novel obesity phenotyping system based on body adiposity and waist circumference
European Journal of Internal Medicine, Vol. 124, pp. 54-60
-
Consenso del grupo de trabajo de los trastornos de la conducta alimentaria de SENPE (GTTCA-SENPE). Evaluación y tratamiento médico-nutricional en la anorexia nerviosa. Actualización 2023
Nutricion hospitalaria, Vol. 41, Núm. 1, pp. 1-60
-
Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes
Cellular and Molecular Life Sciences, Vol. 81, Núm. 1
-
Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism
Frontiers in Endocrinology, Vol. 15
-
Does the Prevalence of Obesity in the Different Regions of Spain Influence the Attitudes, Perception, and Barriers to Its Treatment?
Obesity Facts, Vol. 17, Núm. 3, pp. 264-273
-
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Obesity Facts, Vol. 17, Núm. 4, pp. 374-444
-
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Journal of Hepatology, Vol. 81, Núm. 3, pp. 492-542
-
Enhancing the management of chronic diseases in clinical practice: The CARABELA methodology
Journal of Healthcare Quality Research
-
Epicardial and liver fat implications in albuminuria: a retrospective study
Cardiovascular Diabetology, Vol. 23, Núm. 1
-
FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease
Clinical Nutrition, Vol. 43, Núm. 9, pp. 2221-2233
-
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
European Journal of Internal Medicine, Vol. 119, pp. 13-30
-
Impact of primary aldosteronism on kidney function: Results from the SPAIN-ALDO registry
Journal of Hypertension, Vol. 42, Núm. 10, pp. 1805-1812
-
Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes
European Journal of Clinical Investigation, Vol. 54, Núm. 8
-
Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register
Endocrine, Vol. 84, Núm. 2, pp. 683-693
-
Localization, traffic and function of Rab34 in adipocyte lipid and endocrine functions
Journal of Biomedical Science, Vol. 31, Núm. 1
-
Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists
Endocrinologia, Diabetes y Nutricion, Vol. 71, Núm. 4, pp. 149-151
-
Multidisciplinary Delphi consensus on challenges and key factors for an optimal care model in chronic kidney disease
Nefrologia, Vol. 44, Núm. 5, pp. 678-688
-
Patients' Persistent Symptoms, Clinician Demographics, and Geo-Economic Factors Are Associated with Choice of Therapy for Hypothyroidism by European Thyroid Specialists: The “THESIS” Collaboration
Thyroid, Vol. 34, Núm. 4, pp. 429-441
-
Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry
High Blood Pressure and Cardiovascular Prevention, Vol. 31, Núm. 1, pp. 43-53
-
Revisiting the beyond BMI paradigm in excess weight diagnosis and management: A call to action
European Journal of Clinical Investigation, Vol. 54, Núm. 7